About Optimus Drugs Private Limited
Data last updated:
Optimus Drugs Private Limited is a private limited company based in Hyderabad, Telangana, India, a subsidiary of Sekhmet Pharmaventures Private Limited. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 02 December 2003 and has been in existence for over 23 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24239TG2003PTC042155. Its GSTIN is 36AAHCS8074N1ZL (Telangana). The company holds 4 GST registrations, of which 3 are active.
The company has an authorised share capital of ₹410 Cr and a paid-up capital of ₹35.14 Cr. It was formerly known as Surya Kiran Labs Private Limited. It is led by directors including Srinivasareddy Desireddy and Durga Prasad Reddy Avula.
Its last annual general meeting (AGM) was held on 31 January 2025, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Raheja Mindspace IT Park, Hyderabad, Telangana.
As per the financials filed for FY 2024, the company reported a revenue of ₹713.55 Cr, a decline of 41% compared to the previous year. For the same year it recorded a net loss of ₹50.59 Cr (net margin -7.1%) and EBITDA of ₹6.25 Cr (EBITDA margin 0.9%). Revenue has grown at a compounded annual rate (CAGR) of 12% over three years and 14% over five years.
The company has about 895 employees on its provident fund (EPFO) records. Its group structure includes 2 subsidiaries.
The company is associated with 1 brand: Optimus Pharma. As per MCA filings, the company has open charges of ₹188.61 Cr and satisfied charges of ₹167.44 Cr on record. Court records list 26 cases involving the company, including 14 filed by the company and 12 filed against it; 8 cases are pending. The company has 20 deals on record (9 secondary share transfers, 8 funding rounds, 2 rights issues), with disclosed funding of ₹1,516.58 Cr; the latest was in April 2024. Its 4 peer companies in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 3 larger and 1 smaller; the largest is Sterile India Private Limited with revenue of ₹791.14 Cr. The company has 20 MSME Form 1 returns on record between 2019 and 2024, listing 2,948 overdue payments to 298 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website optimuspharma.com.
Company details
CIN history
Optimus Drugs has one previous CIN (Corporate Identification Number): U24239AP2003PTC042155. The current CIN is U24239TG2003PTC042155, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24239TG2003PTC042155 | Current |
| U24239AP2003PTC042155 | Previous |
Contact details
Optimus Drugs Private Limited's registered office is in Hyderabad, Telangana. Its website is optimuspharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address7th Floor Maximus Towers 2A, Raheja Mindspace IT Park Hitec City, Hyderabad, Telangana, India – 500081
- IndustryPharma, API Manufacturers
To see the full contact details of Optimus Drugs Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Optimus Drugs operates one associated brand: Optimus Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| APIs, advanced intermediates, and formulations are manufactured. | optimuspharma.com |
Business activity
The main business activity of Optimus Drugs is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Optimus Drugs Private Limited, buy the company report.
Financials of Optimus Drugs Private Limited
FY 2024 filings availableOptimus Drugs Private Limited reported revenue of ₹713.55 Cr (down 41% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue fell 41% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 14%. EBITDA fell 92% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹6.25 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹50.59 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.9% | ||||
| Net Profit Margin | -7.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Optimus Drugs Private Limited, buy the company report.
Board of directors of Optimus Drugs Private Limited
Optimus Drugs has 5 current directors and 16 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Srinivasareddy Desireddy Also directs: Bay Sands Projects LLP, Optimity & Nivan Habitat LLP, Orygamus Laboratories Private Limited and 1 more | Director | 30 Mar 2006 | 20 Years 7 Months | Current |
| Santosh Kumar Mahil Also directs: Optimus Pharma Private Limited, Optimus Life Science Private Limited, Anjan Drug Private Limited and 1 more | Additional Director | 26 Jun 2025 | 1 Years 4 Months | Current |
| Sumit Mohan Nadgir Also directs: Optimus Pharma Private Limited, Optimus Life Science Private Limited, Anjan Drug Private Limited and 2 more | Additional Director | 01 Apr 2025 | 1 Years 7 Months | Current |
| Durga Prasad Reddy Avula | Director | 22 Sep 2022 | 4 Years 1 Months | Current |
| Uma Rao | Director | 09 May 2024 | 2 Years 5 Months | Current |
Peer comparison
Optimus Drugs Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sterile India Private Limited | ₹791.14 Cr (FY 2025) | -13.0% | New Delhi, Delhi, India | |||
| Symbiotec Pharmalab Limited | ₹755.98 Cr (FY 2025) | 5.0% | Mhow, Madhya Pradesh, India | |||
| Tagoor Laboratories Private Limited | ₹719.28 Cr (FY 2022) | 55.0% | Andhra Pradesh, India | |||
| Optimus Drugs Private Limitedthis company | ₹713.55 Cr (FY 2024) | -₹50.59 Cr | -7.1% | -41.0% | 895 | Hyderabad, Telangana, India |
| Dasami Lab Private Limited | ₹694.39 Cr (FY 2025) | 22.0% | Chityal, Telangana, India |
To see the full peer comparison of Optimus Drugs Private Limited, buy the company report.
Shareholding
The shareholding of Optimus Drugs Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Optimus Drugs Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 11 Nov 2022 | 100644849 | Axis Bank Limited | ₹3.61 Cr | Open | |
| 10 May 2022 | 100595848 | Hdfc Bank Limited | ₹1 Cr | Open | |
| 16 Sep 2017 | 100137188 | Hdfc Bank Limited | ₹55 Cr | Open | |
| 15 Sep 2017 | 100163795 | Hdfc Bank Limited | ₹40 Cr | Open | |
| 25 Jun 2015 | 10577123 | Others | ₹64 Cr | Open |
To see the full charge records of Optimus Drugs Private Limited, buy the company report.
Total charge records: 16 View all charges
Deals & funding
Optimus Drugs Private Limited has 20 deals on record (9 secondary share transfers, 8 funding rounds, 2 rights issues), with disclosed funding of ₹1,516.58 Cr; the latest was in April 2024.
Deals on record (5 of 20)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Nov 2021 | Funding round | ₹10.99 Cr | Investors: Unichem Laboratories Limited , Srinivas Reddy Desireddy HUF, 2 individuals |
| Nov 2018 | Secondary share transfer | Undisclosed | Buyer: Unichem Laboratories Limited Seller: an individual |
| Nov 2018 | Funding round | ₹35 Cr | Investors: Unichem Laboratories Limited |
| Mar 2015 | Secondary share transfer | Undisclosed | Buyer: 4 individuals Seller: Twine Steel Private Limited |
| Mar 2014 | Funding round | ₹4.94 Cr | Investors: Twine Steel Private Limited , 3 individuals |
To see the full deal history of Optimus Drugs Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Optimus Drugs Private Limited has 26 court cases on record: 14 filed by Optimus Drugs, 12 filed against it. 8 cases are pending and 18 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 17 | 6 | 3 |
| District courts | 6 | 4 | 4 |
| NCLT | 2 | 1 | 0 |
| Supreme Court | 1 | 1 | 1 |
Cases on record (5 of 26)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai City Civil Court, Maharashtra | Court case (Sum.Civ.Suit) | Filed against the company by Simson Pharma Limited | Pending |
| Madras High Court | Court case (CMA(PT)) | Filed by the company against Symed Labs Ltd and 1 other | Pending |
| Madras High Court | Interim or miscellaneous application | Filed by the company against Symed Labs Ltd and 1 other | Pending |
| Bombay High Court | Court case (CARAP) | Filed against the company by Gujarat Themis Biosyn Limited | Disposed |
| High Court, TAMIL NADU | Court case (WP(IPD)) | Filed by the company against Symed Labs Limited, A Company and 3 others | Disposed |
To see the full case history of Optimus Drugs Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Optimus Drugs Private Limited was last rated by Indiarating on 21 Jul 2021.
| Rating agency | Rated on | Rating |
|---|---|---|
| Indiarating | 21 Jul 2021 |
To see the full credit ratings and regulatory alerts of Optimus Drugs Private Limited, buy the company report.
MSME payment delays
Optimus Drugs Private Limited has 20 MSME Form 1 returns on record between 2019 and 2024, listing 2,948 overdue payments to 298 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 298)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| Raddiot Advisory Services Private Limited | |||
| Godavari Plasto Containers Private Limited | |||
| an individual supplier | |||
| an individual supplier |
To see the full MSME payment records of Optimus Drugs Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Group structure & subsidiaries
Optimus Drugs has 2 subsidiary companies. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares held |
|---|---|---|
| Optimus Life Science Private Limited | U24110TG2020PTC139669 | |
| Optimus Pharma Private Limited | U24239TG2004PTC044232 |
To see the full group structure of Optimus Drugs Private Limited, buy the company report.
Employees & EPFO
Optimus Drugs Private Limited has a workforce of 895 employees on its EPFO records as of Mar 10, 2025, across 1 active EPFO establishment.
GST
Optimus Drugs has 4 GST registrations: 3 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAHCS8074N1ZL | Telangana | Active | 01 Jul 2017 |
| 36AAHCS8074N2ZK | Telangana | Active | 01 May 2024 |
| 37AAHCS8074N2ZI | Andhra Pradesh | Active | 14 Mar 2018 |
To see the full GST registrations and return filing status of Optimus Drugs Private Limited, buy the company report.
Recent activity
Optimus Drugs Private Limited has 21 board changes on record since 2006: 8 appointments and 13 cessations. The latest: Lakshay Kataria ceased to be Additional Director on 26 Jun 2025.
48 earlier events are in the company report.
News
Frequently asked questions
Optimus Drugs is an active private limited company based in Hyderabad, Telangana, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 02 December 2003 (23+ years old) and is registered under CIN U24239TG2003PTC042155.
Optimus Drugs has 5 current directors:
- Srinivasareddy Desireddy - Director
- Santosh Kumar Mahil - Additional Director
- Sumit Mohan Nadgir - Additional Director
- Durga Prasad Reddy Avula - Director
- Uma Rao - Director
The latest financial statements of Optimus Drugs on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 31 January 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Optimus Drugs is 36AAHCS8074N1ZL, registered in Telangana. The company has 4 GST registrations in all, of which 3 are active and 1 is cancelled or inactive. Other active GSTINs include 36AAHCS8074N2ZK (Telangana), 37AAHCS8074N2ZI (Andhra Pradesh).
The CIN (Corporate Identification Number) of Optimus Drugs is U24239TG2003PTC042155. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Optimus Drugs has 26 court cases on record: 14 filed by the company and 12 filed against it. 8 are pending. Most are in the high courts.
Optimus Drugs was incorporated on 02 December 2003, making it 23+ years old. It is registered with the Registrar of Companies, Hyderabad.
Optimus Drugs has 20 deals on record (9 secondary share transfers, 8 funding rounds, 2 rights issues), with disclosed funding of ₹1,516.58 Cr; the latest was in April 2024.
The peers of Optimus Drugs by revenue are Sterile India Private Limited, Symbiotec Pharmalab Limited, Tagoor Laboratories Private Limited, Dasami Lab Private Limited, all in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Lakshay Kataria ceased to be Additional Director on 26 Jun 2025. Santosh Kumar Mahil was appointed as Additional Director on 26 Jun 2025. Lakshay Kataria was appointed as Additional Director on 01 Apr 2025. Optimus Drugs has 21 board changes on record in total.
Optimus Drugs has 20 MSME Form 1 returns on record between 2019 and 2024, listing 2,948 overdue payments to 298 micro and small suppliers. The latest return was filed on 26 Apr 2024.
Optimus Drugs can be reached through the website optimuspharma.com. Its registered office is in Hyderabad, Telangana, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
